BioLife Solutions, Inc. (BLFS) vs Novavax, Inc. (NVAX)
A side-by-side comparison of BioLife Solutions, Inc. and Novavax, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BLFS
BioLife Solutions, Inc.
$38.61HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
NVAX
Novavax, Inc.
$11.25HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
Total return — BLFS vs NVAX
growth of $100 · dividends reinvested · last 10yBLFS +2119.0% (+36.3%/yr)NVAX -59.7% (-8.7%/yr)BLFS compounded faster over this window
Log scale — wide-divergence pair
BLFS NVAX
BLFS vs NVAX: by the numbers
- •BLFS is the larger company ($1.89B vs $1.85B market cap).
- •BLFS is profitable (49.06% net margin) while NVAX runs a net loss (-59.87%).
- •NVAX grew revenue faster over the past five years (118.86% vs 6.78% CAGR).
Metrics side by side
Valuation
| Metric | BLFS | NVAX |
|---|---|---|
| P/E ratio | 37.72 | N/A |
| Forward P/E | 64.35 | N/A |
| P/S ratio | 18.35 | 4.47 |
| P/B ratio | 4.49 | N/A |
| EV / EBITDA | 170.26 | N/A |
Profitability
| Metric | BLFS | NVAX |
|---|---|---|
| Gross margin | 64.48% | 93.67% |
| Operating margin | -1.12% | 50.14% |
| Net margin | 49.06% | -59.87% |
| ROE | 12.01% | N/A |
| ROIC | 1.72% | -36.37% |
Growth (annualized)
| Metric | BLFS | NVAX |
|---|---|---|
| Revenue CAGR (5Y) | 6.78% | 118.86% |
| Total return CAGR (5Y) | -0.77% | -40.61% |
Frequently asked
- Which has grown faster, BLFS or NVAX?
- Over the past five years, NVAX grew revenue faster — BLFS at a 6.78% CAGR versus NVAX at 118.86%.
- Is BLFS or NVAX more profitable?
- BLFS runs the higher net margin — BLFS at 49.06% versus NVAX at -59.87%.
- How have BLFS and NVAX total returns compared?
- Over the past 10 years, BLFS delivered 36.27% and NVAX delivered -10.98% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
BioLife Solutions P/E ratioBioLife Solutions ROENovavax ROEBioLife Solutions operating marginNovavax operating marginBioLife Solutions revenue growthNovavax revenue growthBioLife Solutions free cash flowNovavax free cash flow
BioLife Solutions & Novavax appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.